These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28002131)

  • 1. Premedication Use Before Infliximab Administration: A Cross-sectional Analysis.
    Picoraro J; Winberry G; Siegel CA; El-Matary W; Moses J; Grossman A; Park KT
    Inflamm Bowel Dis; 2017 Jan; 23(1):174-180. PubMed ID: 28002131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Premedication Use in Preventing Acute Infliximab Infusion Reactions in Patients with Inflammatory Bowel Disease: A Single Center Cohort Study.
    Gold SL; Cohen-Mekelburg S; Schneider Y; Shen N; Faggen A; Rupert A; Scherl EJ; Bosworth B; Steinlauf A
    Inflamm Bowel Dis; 2017 Oct; 23(10):1882-1889. PubMed ID: 28837521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical management of inflammatory bowel disease among Canadian gastroenterologists.
    Jones J; Panaccione R; Russell ML; Hilsden R
    Can J Gastroenterol; 2011 Oct; 25(10):565-9. PubMed ID: 22059162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Rapid vs Standard Infliximab Infusions in the Pediatric Population.
    Rozette NA; Hellauer CM; McKee C; Vazifedan T; Gabriel CA; Dice JE; Yokois NU
    Inflamm Bowel Dis; 2018 Aug; 24(9):2007-2014. PubMed ID: 29788416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation in infliximab administration practices in the treatment of pediatric inflammatory bowel disease.
    Adler J; Sandberg KC; Shpeen BH; Eder SJ; Dhanani M; Clark SJ; Freed GL
    J Pediatr Gastroenterol Nutr; 2013 Jul; 57(1):35-8. PubMed ID: 23459317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in Care of Inflammatory Bowel Diseases Patients in Crohn's and Colitis Foundation of America Partners: Role of Gastroenterologist Practice Setting in Disease Outcomes and Quality Process Measures.
    Weaver KN; Kappelman MD; Sandler RS; Martin CF; Chen W; Anton K; Long MD
    Inflamm Bowel Dis; 2016 Nov; 22(11):2672-2677. PubMed ID: 27755268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Premedication and infusion reactions with infliximab: results from a pediatric inflammatory bowel disease consortium.
    Jacobstein DA; Markowitz JE; Kirschner BS; Ferry G; Cohen SA; Gold BD; Winter HS; Heyman MB; Baldassano RN
    Inflamm Bowel Dis; 2005 May; 11(5):442-6. PubMed ID: 15867583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of Severe Infusion Reactions Associated With Outpatient Infusion of Infliximab Without Premedications.
    Hutsell SQ; Wu M; Park KT
    J Pediatr Gastroenterol Nutr; 2017 Oct; 65(4):430-431. PubMed ID: 28937551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infliximab in inflammatory bowel disease. Is premedication necessary?
    Nuñez F P; Quera R; Simian D; Flores L; Figueroa C; Ibañez P; Kronberg U; Lubascher J; Pizarro G
    Gastroenterol Hepatol; 2021 May; 44(5):321-329. PubMed ID: 33386199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Premedication as primary prophylaxis does not influence the risk of acute infliximab infusion reactions in immune-mediated inflammatory diseases: A systematic review and meta-analysis.
    Fumery M; Tilmant M; Yzet C; Brazier F; Loreau J; Turpin J; Le Mouel JP; Goeb V; Nguyen-Khac E; Singh S; Dupas JL; Diouf M
    Dig Liver Dis; 2019 Apr; 51(4):484-488. PubMed ID: 30686715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Premedication with corticosteroids does not impact the pharmacokinetics of infliximab in inflammatory bowel disease irrespective of azathioprine cotreatment.
    Larsen L; Jess T; Drewes AM; Dige A; Fallingborg J; Jacobsen BA; Aagaard B; Agnholt J
    Eur J Gastroenterol Hepatol; 2019 Aug; 31(8):964-967. PubMed ID: 31094854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing acute infusion reactions in inflammatory bowel disease patients treated with infliximab in the era of scheduled maintenance therapy.
    Duron C; Goutte M; Pereira B; Bommelaer G; Buisson A
    Eur J Gastroenterol Hepatol; 2015 Jun; 27(6):705-11. PubMed ID: 25856689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infliximab therapy in children and adolescents with inflammatory bowel disease.
    Veres G; Baldassano RN; Mamula P
    Drugs; 2007; 67(12):1703-23. PubMed ID: 17683171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practice Variations in the Management of Inflammatory Bowel Disease Between Pediatric and Adult Gastroenterologists.
    Assa A; Avni I; Ben-Bassat O; Niv Y; Shamir R
    J Pediatr Gastroenterol Nutr; 2016 Mar; 62(3):372-7. PubMed ID: 26284542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does infliximab short infusion have a beneficial impact on the quality of life in patients with inflammatory bowel diseases? A single centre prospective evaluation.
    Principi M; Losurdo G; La Fortezza RF; Lopolito P; Lovero R; Grillo S; Bringiotti R; Ierardi E; Di Leo A
    J Gastrointestin Liver Dis; 2015 Jun; 24(2):165-70. PubMed ID: 26114175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastroenterologists' prescribing of infliximab for Crohn's disease: a national survey.
    St Charles M; Smith SR; Beardsley R; Fedder DO; Carter-Pokras O; Cross RK
    Inflamm Bowel Dis; 2009 Oct; 15(10):1467-75. PubMed ID: 19266574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infliximab-induced skin manifestations in patients with inflammatory bowel disease.
    Hellström AE; Färkkilä M; Kolho KL
    Scand J Gastroenterol; 2016; 51(5):563-71. PubMed ID: 26728295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Timing of Last Preoperative Dose of Infliximab Does Not Increase Postoperative Complications in Inflammatory Bowel Disease Patients.
    Alsaleh A; Gaidos JK; Kang L; Kuemmerle JF
    Dig Dis Sci; 2016 Sep; 61(9):2602-7. PubMed ID: 27126205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nurse-led accelerated procedure for infliximab infusion is well tolerated and effective in patients with inflammatory bowel disease.
    Michielan A; Martinato M; Favarin A; Zanotto V; Caccaro R; Caruso A; Sturniolo GC; D'Incà R
    Dig Liver Dis; 2015 May; 47(5):372-7. PubMed ID: 25708258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid Infliximab Infusion in Children: A Multicenter Retrospective Cohort Study.
    Lev-Tzion R; Assa A; Yerushalmi B; Lahad A; Friedman M; Ledder O; Turner D
    J Pediatr Gastroenterol Nutr; 2017 Nov; 65(5):e101-e103. PubMed ID: 29064928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.